BSDC1

Model summary

A cytosolic adaptor that uses a central BSD module to assemble inhibitory complexes controlling growth and cytoskeletal dynamics. It restrains cell growth and proliferation by dampening TORC1 signaling and contributes to the stabilization of both microtubules and microfilaments. The scaffold likely cycles between the cytosol and membrane-proximal secretory organelles, where it organizes signaling assemblies that couple TORC1 suppression to cytoskeletal organization.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide carries a central BSD module: IPR005607 (BSD domain, residues 146–203) sits within a broader IPR035925 (BSD domain superfamily, residues 108–208), and the entire sequence is classified by IPR051494 (Synapse-associated protein 1/BSD domain-containing protein 1 family, residues 3–427). The ordered layout—an internal BSD domain embedded in its superfamily envelope and encompassed by a synapse-associated family signature—defines a non-enzymatic adaptor scaffold. BSD domains are compact helical modules that mediate selective protein–protein interactions and assembly of regulatory complexes rather than catalysis. This architecture causally dictates a molecular function centered on multivalent binding, consistent with GO:0005515 protein binding.

2. 02

   A BSD-centered scaffold typically tunes signaling by nucleating inhibitory assemblies.

   Here, the family context and the modular binding core support a role in dampening growth pathways. The most parsimonious biological process is suppression of TORC1 signaling, aligning with GO:1904262 negative regulation of TORC1 signaling. Mechanistically, a BSD adaptor can recruit upstream regulators that attenuate TORC1 activation—such as components that favor Rag-dependent inhibition or that bias the pathway toward inactivation—thereby restraining cell growth and proliferation. The same scaffold logic extends to cytoskeletal control: BSD-mediated assemblies at membrane–cytoskeleton interfaces can stabilize microtubules and microfilaments by coordinating tubulin- and actin-associated factors.

3. 03

   Cellular placement follows from both the domain logic and the observed distribution.

   A soluble adaptor without transmembrane segments is expected to partition between cytosol and membrane-proximal compartments. The experimentally observed cytoplasm/cytosol localization is congruent with GO:0005829 cytosol. The additional presence at the endoplasmic reticulum and Golgi apparatus indicates a membrane-associated regulatory role at secretory pathway hubs, which are known to interface with cytoskeletal tracks and signaling nodes. Thus, I infer occupancy of the cytoplasm and transient association with ER and Golgi membranes, consistent with a mobile scaffold that assembles and disperses complexes according to signaling state.

4. 04

   Integrating these lines, I hypothesize that the protein operates as a cytosolic BSD-domain adaptor that suppresses TORC1 signaling and stabilizes cytoskeletal systems.

   By concentrating inhibitory regulators of TORC1 at ER/Golgi-proximal sites and along cytoskeletal routes, it likely coordinates growth restraint with microtubule and actin homeostasis. Candidate interaction partners include TORC1 pathway regulators (e.g., Ragulator–Rag modules and their effectors), microtubule-associated proteins, and actin-binding factors that together produce a tunable inhibitory scaffold responsive to cellular state.